XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -50.38%322.92M | 3.40%1.1B | 2.07%650.75M | -4.14%1.07B | 4.59%637.58M | -12.95%1.11B | -18.73%609.58M | 99.86%1.28B | 100.17%750.08M | -56.75%639.44M |
Operating income | -50.38%322.92M | 3.40%1.1B | 2.07%650.75M | -4.14%1.07B | 4.59%637.58M | -12.95%1.11B | -18.73%609.58M | 99.86%1.28B | 100.17%750.08M | -56.75%639.44M |
Cost of sales | 54.68%-128.58M | -2.22%-506.77M | -0.03%-283.72M | 3.70%-495.77M | -9.61%-283.65M | 19.40%-514.83M | 38.62%-258.78M | -142.23%-638.74M | -280.17%-421.6M | 64.57%-263.7M |
Operating expenses | 54.68%-128.58M | -2.22%-506.77M | -0.03%-283.72M | 3.70%-495.77M | -9.61%-283.65M | 19.40%-514.83M | 38.62%-258.78M | -142.23%-638.74M | -280.17%-421.6M | 64.57%-263.7M |
Gross profit | -47.05%194.34M | 4.42%595.86M | 3.70%367.03M | -4.52%570.65M | 0.89%353.93M | -6.50%597.67M | 6.79%350.8M | 70.13%639.24M | 24.51%328.48M | -48.81%375.74M |
Administrative expenses | 28.69%-53.07M | 26.53%-130.06M | 31.11%-74.42M | 16.06%-177.01M | -10.63%-108.01M | -2.31%-210.89M | -5.12%-97.64M | -30.26%-206.12M | -37.82%-92.88M | -13.65%-158.24M |
Profit from asset sales | ---- | ---- | ---- | ---- | ---- | --32.94M | ---- | ---- | ---- | ---- |
Revaluation surplus | -425.78%-65.67M | -557.17%-156.7M | 2,791.46%20.16M | 126.90%34.28M | 98.18%-749K | -190.07%-127.43M | -458.19%-41.1M | 80.79%-43.93M | -88.67%11.47M | -124.59%-228.63M |
-Changes in the fair value of investment property | -425.78%-65.67M | -557.17%-156.7M | 2,791.46%20.16M | 126.90%34.28M | 98.18%-749K | -190.07%-127.43M | -458.19%-41.1M | 80.79%-43.93M | -88.67%11.47M | -124.59%-228.63M |
Operating interest expense | ---- | ---- | ---- | ---- | -26.72%-109.08M | 5.85%-178.41M | 10.30%-86.08M | 13.64%-189.51M | ---95.96M | ---219.44M |
Special items of operating profit | 10.91%33.27M | 3.21%47.15M | 18.10%30M | -24.35%45.68M | -35.18%25.4M | 93.24%60.39M | 112.58%39.18M | -15.61%31.25M | 41.10%18.43M | 62.23%37.03M |
Operating profit | -68.24%108.87M | -24.78%356.25M | 112.25%342.77M | 171.77%473.59M | -2.23%161.49M | -24.54%174.26M | -2.59%165.17M | 219.32%230.93M | -45.45%169.55M | -112.51%-193.54M |
Financing cost | 5.19%-173.17M | -44.85%-386M | ---182.65M | ---266.48M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | 1,403.26%35.54M | 33.50%31.14M | -115.52%-2.73M | -57.20%23.32M | -29.66%17.57M | -47.15%54.5M | -52.43%24.98M | -30.27%103.12M | -53.56%52.51M | -59.39%147.88M |
Share of profit from joint venture company | ---1.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Earning before tax | -119.06%-30.01M | -99.40%1.38M | -12.10%157.39M | 0.73%230.44M | -5.83%179.06M | -31.52%228.76M | -14.37%190.15M | 831.65%334.05M | -29.53%222.06M | -102.58%-45.66M |
Tax | 85.37%-19.11M | 68.92%-45.24M | -35.86%-130.57M | -9.24%-145.53M | -2.36%-96.11M | 38.36%-133.22M | 32.17%-93.89M | -1,988.40%-216.11M | -51.04%-138.42M | 102.48%11.44M |
After-tax profit from continuing operations | -283.10%-49.11M | -151.65%-43.86M | -67.67%26.82M | -11.13%84.91M | -13.82%82.95M | -18.99%95.54M | 15.08%96.26M | 444.73%117.94M | -62.57%83.64M | -102.62%-34.21M |
Earning after tax | -283.10%-49.11M | -151.65%-43.86M | -67.67%26.82M | -11.13%84.91M | -13.82%82.95M | -18.99%95.54M | 15.08%96.26M | 444.73%117.94M | -62.57%83.64M | -102.65%-34.21M |
Minority profit | -30.61%20.16M | -56.07%22.81M | -23.99%29.05M | 30.36%51.93M | 1.17%38.22M | -0.57%39.84M | 25.31%37.78M | 257.40%40.07M | -65.21%30.15M | -97.81%11.21M |
Profit attributable to shareholders | -3,004.80%-69.27M | -302.17%-66.67M | -104.99%-2.23M | -40.80%32.98M | -23.51%44.73M | -28.47%55.7M | 9.32%58.48M | 271.45%77.88M | -60.89%53.49M | -105.81%-45.42M |
Basic earnings per share | -3,050.00%-0.126 | -300.00%-0.12 | -104.94%-0.004 | -40.00%0.06 | -26.36%0.081 | -28.57%0.1 | 10.00%0.11 | 275.00%0.14 | -60.00%0.1 | -105.63%-0.08 |
Diluted earnings per share | -3,050.00%-0.126 | -300.00%-0.12 | -104.94%-0.004 | -40.00%0.06 | -26.36%0.081 | -28.57%0.1 | 10.00%0.11 | 275.00%0.14 | -60.00%0.1 | -105.63%-0.08 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.